FOI Request Shows Significantly Higher Reports of Serious Adverse Events and Deaths in Moderna Clinical Trial Participants Who Took the mRNA Jab Compared to the Placebo Group.

The FDA has recently released a massive FOI request that comprises nearly 15,000 pages. It was made public only after a judge ruled in favor of the requester, who took the FDA to court over its refusal to release Moderna's mRNA Covid jab clinical trial documents.

This clinical trial was Moderna's first 2-dose trial of its mRNA-1273 Covid-19 vaccine conducted back in 2020.

One interesting part of Moderna's mRNA-1273 Covid-19 vaccine clinical trial documents is the 218 pages dedicated to serious adverse events (SAEs) reported during follow up after the jabs. These pages categorize the participants into three groups: those who took placebo shots, those who took a placebo and then an mRNA shot, and those who solely took 2 doses of the mRNA shot.

In the placebo group, there were only 5 pages with 7 participants listed as having a serious adverse event. These are pages 2 to 6.

However, when examining the participants flagged for a serious adverse event in the placebo-mRNA jab or solely the 2 doses of the mRNA jab category, there are hundreds of pages with hundreds of participants. These are pages 7 to 208.

Regarding deaths in the clinical trial reports, there was only one death in the placebo group, three deaths in the placebo-mRNA group, and 8 deaths in those who solely took 2 doses of the mRNA jab. All participants were negative for Covid-19 at the time of their death.

The deaths in the 2-dose mRNA participants included cardiac disorders, nervous system issues, pulmonary embolism, stroke, and gastrointestinal bleed. I listed a few of them below.

Additionally, in the placebo-mRNA and 2 dose mRNA group there was one report of sudden death and one report of a participant listed as dying as a result of head trauma from a fall.

Looking at the serious adverse events reported in the placebo-mRNA and those who solely took 2 doses of the mRNA jab, there was a significant number of participants during follow-up who were still recovering or not yet recovered. This group included participants who experienced severe bouts of Covid-19, cardiac issues, other infections including RSV, eye issues, gastrointestinal disorders, tooth decay, sepsis, musculoskeletal and connective tissue disorders, renal and urinary disorders, nervous system disorders, skin and subcutaneous tissue disorders, pancreatic cancer, Bells Palsy, Shingles and many others.

The Canadian Independent will continue to go through the FOI documents and bring you any other relevant findings.